Safe and effective interferon-beta gene therapy for the treatment of multiple sclerosis by regulating biological activity through the design of interferon-beta-galectin-9 fusion proteins-Reference-Cited by-同舟云学术

Safe and effective interferon-beta gene therapy for the treatment of multiple sclerosis by regulating biological activity through the design of interferon-beta-galectin-9 fusion proteins

Published:2018-01 Issue:1 Volume:536 Page:310-317
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Hamana Atsushi,Takahashi Yuki,Tanioka Akane,Nishikawa Makiya,Takakura Yoshinobu

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development (AMED)

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference21 articles.

1. TIM-3 in autoimmunity;Anderson;Curr. Opin. Immunol.,2006

2. Interferon-β suppresses murine Th1 cell function in the absence of antigen-presenting cells;Boivin;PLoS One,2015

3. Cerebrospinal fluid concentration of galectin-9 is increased in secondary progressive multiple sclerosis;Burman;J. Neuroimmunol.,2016

4. Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection;Correale;Acta Neurol. Scand.,2015

5. Multiple sclerosis–the plaque and its pathogenesis;Frohman;N. Engl. J. Med.,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Cytosolic DNA Sensor Agonist Using GALA Peptide-Conjugated DNA and Long Single-Stranded DNA;Molecular Pharmaceutics;2024-02-06

2. Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier;Advanced Functional Materials;2024-01-04

3. Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview;Life Sciences;2023-12

4. Nose to brain delivery of ibudilast micelles for treatment of multiple sclerosis in an experimental autoimmune encephalomyelitis animal model;International Journal of Pharmaceutics;2023-05

5. Regnase-1 Deficiency Restrains Klebsiella pneumoniae Infection by Regulation of a Type I Interferon Response;mBio;2022-02-22